S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
ASX:BIT

Biotron Competitors

Add
Compare
Today's Range N/A
50-Day Range
A$0.09
MA: A$0.09
A$0.09
52-Week Range N/A
Volume1.03 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Biotron (ASX:BIT) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying BIT stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Biotron, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

(CHV) (CNSX:CHV) and Biotron (ASX:BIT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (CHV) and Biotron, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Biotron0000N/A

Profitability

This table compares (CHV) and Biotron's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
BiotronN/AN/AN/A

Valuation and Earnings

This table compares (CHV) and Biotron's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Biotron$853,026.000.00$-4,211,597.95A($0.01)N/A

(CHV) has higher earnings, but lower revenue than Biotron.

Summary

Biotron beats (CHV) on 1 of the 1 factors compared between the two stocks.

(DDXS) (OTCMKTS:DDXS) and Biotron (ASX:BIT) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares (DDXS) and Biotron's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
Biotron$853,026.000.00$-4,211,597.95A($0.01)N/A

(DDXS) has higher earnings, but lower revenue than Biotron.

Profitability

This table compares (DDXS) and Biotron's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
BiotronN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for (DDXS) and Biotron, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Biotron0000N/A

Summary

Biotron beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Biotron (ASX:BIT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

Profitability

This table compares (PREV) and Biotron's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
BiotronN/AN/AN/A

Valuation and Earnings

This table compares (PREV) and Biotron's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
Biotron$853,026.000.00$-4,211,597.95A($0.01)N/A

(PREV) has higher earnings, but lower revenue than Biotron.

Analyst Ratings

This is a breakdown of current ratings and target prices for (PREV) and Biotron, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Biotron0000N/A

Summary

Biotron beats (PREV) on 1 of the 1 factors compared between the two stocks.

Biotron (ASX:BIT) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, profitability, institutional ownership, dividends and risk.

Profitability

This table compares Biotron and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BiotronN/AN/AN/A
(TNGN)N/AN/AN/A

Valuation & Earnings

This table compares Biotron and (TNGN)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biotron$853,026.000.00$-4,211,597.95A($0.01)N/A
(TNGN)N/AN/AN/AN/AN/A

(TNGN) has lower revenue, but higher earnings than Biotron.

Analyst Recommendations

This is a summary of current recommendations and price targets for Biotron and (TNGN), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Biotron0000N/A
(TNGN)0000N/A

Summary

Biotron beats (TNGN) on 1 of the 1 factors compared between the two stocks.

138267 (COM.TO) (TSE:COM) and Biotron (ASX:BIT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 138267 (COM.TO) and Biotron, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
Biotron0000N/A

Profitability

This table compares 138267 (COM.TO) and Biotron's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
BiotronN/AN/AN/A

Valuation and Earnings

This table compares 138267 (COM.TO) and Biotron's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
Biotron$853,026.000.00$-4,211,597.95A($0.01)N/A

138267 (COM.TO) has higher earnings, but lower revenue than Biotron.

Summary

Biotron beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

17031 (CNSX:MYM) and Biotron (ASX:BIT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability.

Analyst Recommendations

This is a breakdown of current recommendations for 17031 and Biotron, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
170310000N/A
Biotron0000N/A

Valuation and Earnings

This table compares 17031 and Biotron's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
17031N/AN/AN/AN/AN/A
Biotron$853,026.000.00$-4,211,597.95A($0.01)N/A

17031 has higher earnings, but lower revenue than Biotron.

Profitability

This table compares 17031 and Biotron's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
17031N/AN/AN/A
BiotronN/AN/AN/A

Summary

Biotron beats 17031 on 1 of the 1 factors compared between the two stocks.


Biotron Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5$2.95flatC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
4BB
4basebio UK Societas
0.3N/AN/A£0.00N/A0.00Insider Buying
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
Abzena plc (ABZA.L) logo
ABZA
Abzena plc (ABZA.L)
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.25 million0.00High Trading Volume
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$4.23 million0.00High Trading Volume
Gap Up
ADTX
ADiTx Therapeutics
1.0$3.22flat$0.00N/A0.00Decrease in Short Interest
Gap Down
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
AGNPF
Algernon Pharmaceuticals
0.0$0.28flat$0.00N/A0.00Gap Down
Almirall logo
LBTSF
Almirall
0.5$12.40flat$0.00N/A0.00Increase in Short Interest
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00$268,259.000.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
CBDC
Apotheca Biosciences
0.4$0.03flat$0.00N/A0.00High Trading Volume
Gap Up
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
CDMOP
Avid Bioservices
0.3$30.48flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
AXIM
AXIM Biotechnologies
0.4$0.73flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5$4.51flat$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.88flat$0.00N/A0.00Decrease in Short Interest
BGT
Bio-Gene Technology
0.5N/AN/A$0.00$82,795.000.00High Trading Volume
Gap Up
BNO
Bionomics Limited (BNO.AX)
0.5N/AN/A$0.00$3.19 million0.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.15 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$7.56 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$240,243.000.00High Trading Volume
Gap Up
BCTX
BriaCell Therapeutics
0.0$3.85flat$0.00N/A0.00News Coverage
Gap Down
BTC
BTC Health Limited (BTC.AX)
0.5N/AN/A$0.00$131,934.000.00High Trading Volume
Gap Up
CNBX
Cannabics Pharmaceuticals
0.4$0.40flat$0.00N/A0.00Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid Limited (CDY.AX)
0.8N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
CBBT
Cerebain Biotech
0.0$0.08flat$0.00N/A0.00Increase in Short Interest
Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$18.13flat$0.00N/A0.00
CUV
Clinuvel Pharmaceuticals
0.6N/AN/A$0.00$32.57 million0.00High Trading Volume
Gap Up
CELZ
Creative Medical Technology
0.5$0.04flat$0.00N/A0.00Decrease in Short Interest
Gap Down
CSL Limited (CSL.AX) logo
CSL
CSL Limited (CSL.AX)
0.8N/AN/A$0.00$9.98 billion0.00Dividend Announcement
High Trading Volume
News Coverage
Gap Up
CLXPF
Cybin
1.0$1.36flat$0.00N/A0.00Decrease in Short Interest
CYP
Cynata Therapeutics
0.5N/AN/A$0.00$7.01 million0.00High Trading Volume
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.55flat$0.00N/A0.00Increase in Short Interest
This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.